文献速递妇科

子宫肌瘤聚焦超声消融手术与子宫肌瘤剔除术远期结局比较

[Comparison of the long-term outcomes of focused ultrasound ablation surgery for uterine fibroids and myomectomy].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2022-01-01

回顾性分析2007年1月至2015年1月解放军总医院第一医学中心763例FUAS与1205例子宫肌瘤剔除术患者,两组治疗有效率无统计学差异,10年累积症状复发率及再治疗率均无显著差异;但黏膜下肌瘤FUAS结局更优,浆膜下肌瘤剔除术结局更优,FUAS不良事件发生率更低。

要点

  • FUAS与肌瘤剔除术治疗有效率分别为95.7%与95.5%,无统计学差异。
  • 黏膜下肌瘤FUAS治疗有效率高于剔除术,复发率及再治疗率低于剔除术。
  • 浆膜下肌瘤FUAS治疗有效率低于剔除术,复发率及再治疗率高于剔除术。

核心结论

  • FUAS与子宫肌瘤剔除术均可长期有效改善子宫肌瘤患者临床症状,两种方法疗效相当。

研究设计与样本

  • 回顾性研究纳入2007年1月至2015年1月在解放军总医院第一医学中心行FUAS(763例)或子宫肌瘤剔除术(1205例)的子宫肌瘤患者,随访症状改善、复发、再治疗及不良事件。

主要发现

  • FUAS组与剔除术组治疗有效率分别为95.7%(730/763)与95.5%(1151/1205),无统计学差异(χ²=0.027,P=0.869)。
  • FUAS组1、3、5、8、10年累积症状复发率分别为1.8%、6.8%、11.9%、15.2%、15.9%,累积再治疗率分别为0.7%、4.1%、6.8%、9.9%、11.0%。
  • 剔除术组1、3、5、8、10年累积症状复发率分别为1.8%、5.9%、10.6%、14.2%、14.9%,累积再治疗率分别为0.9%、4.5%、7.8%、10.3%、11.4%,两组累积复发率及再治疗率均无显著差异(P均>0.05)。
  • 肌壁间肌瘤患者两组治疗有效率、复发率及再治疗率均无显著差异(P均>0.05)。
  • 黏膜下肌瘤FUAS组治疗有效率95.9%(235/245)高于剔除术组89.1%(115/129),复发率11.9%(28/235)低于剔除术组27.8%(32/115),再治疗率7.7%(18/235)低于剔除术组17.4%(20/115),差异均有统计学意义(P均<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To compare the long-term outcomes after focused ultrasound ablation surgery (FUAS) versus myomectomy for uterine fibroids. Methods: A retrospective study was conducted on women who were treated by FUAS or myomectomy for uterine fibroids at First Medical Center of Chinese PLA General Hospital from January 2007 to January 2015. Regular follow-up was conducted to evaluate the symptoms relief, symptoms recurrence, the need for re-interventions and complications of the two groups. Results: The effective rates were 95.7% (730/763) and 95.5% (1 151/1 205) in women who were treated by FUAS and myomectomy, no statistical difference was seen between the two groups (χ²=0.027, P=0.869). The cumulative rates of symptoms recurrence at 1 year, 3 years, 5 years, 8 years and 10 years of follow-up in FUAS group were 1.8%, 6.8%, 11.9%, 15.2% and 15.9%, respectively; and the cumulative re-intervention rates were 0.7%, 4.1%, 6.8%, 9.9% and 11.0%, respectively. The cumulative rates of symptoms recurrence at 1 year, 3 years, 5 years, 8 years and 10 years of follow-up in myomectomy group were 1.8%, 5.9%, 10.6%, 14.2% and 14.9%, respectively; and the cumulative re-intervention rates were 0.9%, 4.5%, 7.8%, 10.3% and 11.4%, respectively. No statistical differences were seen between the two groups (all P>0.05). There were no significant differences in the effective rate, symptoms recurrence rate and re-intervention rate between the two groups in patients with intermural fibroids; but the effective rate of FUAS (95.9%, 235/245) was higher than that of myomectomy (89.1%, 115/129), the symptoms recurrence rate (11.9%, 28/235) was lower than that of myomectomy (27.8%, 32/115), and the re-intervention rate (7.7%, 18/235) was lower than that of myomectomy (17.4%, 20/115) in patients with submucosal fibroids, there were significant different (all P<0.05). The effective rate of FUAS (91.0%, 132/145) was lower than that of myomectomy (97.0%, 322/332), the symptoms recurrence rate (32.6%, 43/132) was higher than that of myomectomy (9.9%, 32/322), and the re-intervention rate (22.0%, 29/132) was higher than that of myomectomy group (6.2%, 20/132) in patients with subserosal fibroids, there were significant different (all P<0.01). The incidences of total [1.8% (14/763) vs 21.9% (264/1 205)], minor and moderate adverse events were lower in FUAS group than myomectomy group (all P<0.001). Conclusion: Satisfaction with long-term outcomes after FUAS treatment or myomectomy for uterine fibroids is comparable. 目的: 比较子宫肌瘤聚焦超声消融手术(FUAS)与子宫肌瘤剔除术的远期临床疗效差异。 方法: 回顾性分析2007年1月至2015年1月在解放军总医院第一医学中心行FUAS(FUAS组,763例)及子宫肌瘤剔除术(子宫肌瘤剔除术组,1 205例)的子宫肌瘤患者的临床资料,收集两组患者术前基本情况、影像学数据、手术情况,随访两组术后症状改善、症状复发、再治疗以及不良事件发生情况,并比较两组的差异。 结果: FUAS组与子宫肌瘤剔除术组患者的治疗有效率分别为95.7%(730/763)、95.5%(1 151/1 205),两组比较,差异无统计学意义(χ²=0.027,P=0.869)。FUAS组治疗后1、3、5、8、10年的累积症状复发率分别为1.8%、6.8%、11.9%、15.2%、15.9%,累积再治疗率分别为0.7%、4.1%、6.8%、9.9%、11.0%;子宫肌瘤剔除术组术后1、3、5、8、10年的累积症状复发率分别为1.8%、5.9%、10.6%、14.2%、14.9%,累积再治疗率分别为0.9%、4.5%、7.8%、10.3%、11.4%;两组累积症状复发率及累积再治疗率均无明显差异(P均>0.05)。两组中肌壁间肌瘤患者的治疗有效率、症状复发率及再治疗率均无明显差异(P均>0.05);但FUAS组黏膜下肌瘤患者的治疗有效率(95.9%,235/245)高于子宫肌瘤剔除术组(89.1%,115/129),症状复发率(11.9%,28/235)低于子宫肌瘤剔除术组(27.8%,32/115),再治疗率(7.7%,18/235)低于子宫肌瘤剔除术组(17.4%,20/115),分别比较,差异均有统计学意义(P均<0.05);而FUAS组浆膜下肌瘤患者的治疗有效率(91.0%,132/145)低于子宫肌瘤剔除术组(97.0%,322/332),症状复发率(32.6%,43/132)高于子宫肌瘤剔除术组(9.9%,32/322),再治疗率(22.0%,29/132)高于子宫肌瘤剔除术组(6.2%,20/322),分别比较,差异均有统计学意义(P均<0.01)。FUAS总不良事件发生率[分别为1.8%(14/763)、21.9%(264/1 205)]及轻度、中度不良事件发生率低于子宫肌瘤剔除术组(P均<0.001)。 结论: FUAS与子宫肌瘤剔除术均可长期有效改善子宫肌瘤患者的临床症状,两种方法疗效相当。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu X, Wang W, Tang Y, et al. [Comparison of the long-term outcomes of focused ultrasound ablation surgery for uterine fibroids and myomectomy]. Zhonghua Fu Chan Ke Za Zhi. 2022. PMID: 35484655. doi:10.3760/cma.j.cn112141-20210830-00476

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。